Trial Profile
Role of Erbitux plus a combination of CPT-11/5-fluorouracil/leucovorin/oxaliplatin as neoadjuvant chemotherapy in patients with colorectal liver metastases.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2011
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Irinotecan; Levofolinic acid; Oxaliplatin
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 30 May 2011 New trial record